Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 2,851–2,875 of 27,380 studies, newest first · page 115 of 1096.

October 2025 25

  1. 2025-10-25

    Informal Caregiver Outcomes in Home-Based Dyadic Dementia Interventions: A Scoping Review

    ✓ Peer-reviewed Caregiving Journal of evidence-based social work (2019)

    Key finding: An initial database search yielded 3,977 studies of which 22 were included in this review. +4 more findings

  2. 2025-10-25

    Syringin attenuates Alzheimer's disease-associated neuroinflammation by inhibiting NLRP3 inflammasome activation

    ✓ Peer-reviewed Inflammation and the immune system Phytomedicine : international journal of phytotherapy and phytopharmacology

    Key finding: In the MWM, syringin reduced escape latency. +4 more findings

  3. 2025-10-25

    Cognitive dispersion is associated with white matter hyperintensities in amyloid positive older adults

    ✓ Peer-reviewed Vascular contributions The Clinical Neuropsychologist

    Key finding: Amyloid status moderated associations between IIV-dispersion and WMH, such that higher IIV-dispersion was associated with greater WMH in Aß+ individuals whether WMH was examined as a continuous (B = 0.30, ß = 0.13, p = .006) or a dichotomous variable based on quartiles (odds ratio [OR] = 2.41, p < .001). +3 more findings

  4. 2025-10-25
  5. 2025-10-25
  6. 2025-10-25

    Development of Biotin and Horseradish Peroxidase Labelling against Monoclonal Antibody Amyloid-β42 and Its Application on Enzyme-Linked Immunosorbent Assay

    ✓ Peer-reviewed Treatments Jurnal Penelitian Pendidikan IPA

    Key finding: The molecular mass of the conjugated antibodies was characterized with SDS-PAGE, result shows the pre-conjugated antibody has 150 kDa bands, conjugated antibody with labels is heavier than the pre-conjugated due to the addition of each label. +1 more finding

  7. 2025-10-24

    ApoE is Secreted as a Lipid Nanoparticle by Mammalian Cells: Implications for Alzheimer's Disease Pathogenesis

    ✓ Peer-reviewed Genetics Biochemistry

    Key finding: Compared to ApoE3 or the Alzheimer's disease-protective ApoE2 variant, the recovered yield of the LNP form of the disease-predisposing ApoE4 variant is higher.

  8. 2025-10-24
  9. 2025-10-24
  10. 2025-10-24
  11. 2025-10-24

    Pain, agitation, and delirium practices in Chinese intensive care units: A national multicenter survey study

    ✓ Peer-reviewed Clinical safety Chinese Medical Journal

    Key finding: To the Editor: The standardized management of pain–agitation–delirium (PAD) represents a fundamental component of clinical practice in intensive care units (ICUs).[1] Evidence-based analgesia and sedation strategies not only alleviate patients’ physiological discomfort and psychological distress, but also significantly reduce mechanical ventilation duration, improve long-term prognosis, and optimize healthcare resource allocation.[1,2] Equally crucial is delirium management, as evidenced by studies demonstrating that delirium duration independently predicts mortality risk, hospital stay length, healthcare expenditures, and acquired dementia incidence.[3] Although existing studies have explored PAD management practices, most rely on clinicians’ subjective recall that may distort objective clinical realities and fail to reflect distinctive characteristics.[4] Therefore, this nationwide multicenter cross-sectional study, initiated by the Critical Care Analgesia and Sedation Quality Control Subspecialty Group under the China National Center for Medical Quality Control in Critical Care Medicine, aims to investigate the current status of PAD management in China. +4 more findings

  12. 2025-10-24

    The role of neutrophils, red blood cells, and platelets in the pathology of Alzheimer’s disease

    ✓ Peer-reviewed Disease mechanisms Annals of Medicine

    Key finding: Emerging evidence transcends the traditional central nervous system (CNS)-centric perspective, revealing that neutrophils, red blood cells (RBCs), and platelets may play critical roles in AD pathogenesis by modulating systemic inflammatory responses, disrupting blood-brain barrier integrity, and participating in the CNS-peripheral interactions. +1 more finding

  13. 2025-10-24

    Delta-opioid receptor ameliorates microglia-induced synapse loss by regulating C1q in Alzheimer disease pathology

    ✓ Peer-reviewed Inflammation and the immune system Brain Behavior and Immunity

    Key finding: Consistent with these findings, overexpressing microglial DOR effectively inhibited its shift towards a phagocytotic phenotype and protected co-cultured neurons from lipopolysaccharide (LPS) -induced injury. +1 more finding

  14. 2025-10-24

    Development of [18F]ACI-19626 as a first-in-class brain PET tracer for imaging TDP-43 pathology

    ✓ Peer-reviewed Brain tissue and pathology Nature Communications

    Key finding: Both ligands bind with high affinity to aggregated, but not soluble, TDP-43 in patient brain samples from diverse TDP-43 proteinopathies, including frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP), ALS, and LATE, and in cell models. +4 more findings

  15. 2025-10-24

    Recommended best practices for construct-centered adaptation of the Harmonized Cognitive Assessment Protocol

    ✓ Peer-reviewed Getting a diagnosis The Journals of Gerontology Series B

    Key finding: Recommendations for HCAP adaptation include phases of preparation (assembling local expert teams; resource planning), implementation (construct-centered adaptation guided by local experts), pre-testing (iterative, mixed-methods approach), and field preparation (creating documentation; interviewer training; planning for ongoing quality assurance). +3 more findings

  16. 2025-10-24

    Brain age gap as a predictive biomarker that links aging, lifestyle, and neuropsychiatric health

    ✓ Peer-reviewed Prevention and risk Communications Medicine

    Key finding: The highest-risk group (Q4) shows a 2.8-fold increased risk of Alzheimer’s disease, a 6.4-fold risk of multiple sclerosis, and a 2.4-fold higher mortality risk. +4 more findings

  17. 2025-10-23

    LRRK2 kinase-mediated accumulation of lysosome-associated phospho-Rabs in tauopathies and synucleinopathies

    ✓ Peer-reviewed Brain tissue and pathology Acta neuropathologica

    Key finding: Parkinson's disease (PD) pathogenic mutations in leucine-rich repeat kinase 2 (LRRK2) are associated with endolysosomal dysfunction across cell types, and carriers of LRRK2 mutations variably present with phosphorylated tau and α-synuclein deposits in post-mortem analysis. +2 more findings

  18. 2025-10-23

    Consensus meta-analysis of genome-wide association studies for Alzheimer's disease and related dementia

    ⚠ Preprint — not yet peer-reviewed Genetics medRxiv : the preprint server for health sciences

    Key finding: We identified 91 genetic loci associated with ADRD risk, including 16 which are novel, and 56 which are specifically detected in clinically diagnosed AD cases. +2 more findings

    Scored 48 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  19. 2025-10-23

    Dementia risk literacy in older Australians: beyond knowledge

    ✓ Peer-reviewed Prevention trials Public Health Research & Practice

    Key finding: Participants numbered 3334 and had a median age of 62 years. +4 more findings

  20. 2025-10-23

    Computational Insights into the Destabilization of Baicalein on the Tau Protofibrils Associated with Alzheimer’ s Disease and Chronic Traumatic Encephalopathy

    ✓ Peer-reviewed Disease mechanisms The Journal of Physical Chemistry B

    Key finding: It is revealed that the three-dimensional configurations of the protofibrils in AD and CTE-specific tau filaments are rather similar. +1 more finding

  21. 2025-10-23

    Auditory Hallucinations as the First Symptom of Alzheimer´s Disease – A Case Report

    ✓ Peer-reviewed Brain scans and imaging Current Alzheimer Research

    Key finding: Auditory hallucinations in older age could be the first symptom of AD and even occur before cognitive decline.

  22. 2025-10-23

    Interview – Interview zum Thema: Neue Alzheimer-Therapien: Warum Radiolog:innen ARIA kennen müssen

    ✓ Peer-reviewed Treatments RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren

    Key finding: Elke Hattingen, Direktorin der Klinik für Neuroradiologie am Universitätsklinikum Frankfurt am Main, einen Überblick über die typischen MRT-Befunde, über die bildmorphologischen Verläufe und die Risikofaktoren von ARIA. +4 more findings

  23. 2025-10-23

    Neue Alzheimer-Therapien: Vortrag zu ARIA für eine sichere MRT-Diagnostik

    ✓ Peer-reviewed Treatments RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren

    Key finding: Mit der Einführung neuer Alzheimer-Therapien wie den Anti-Amyloid-Antikörpern Lecanemab und Donanemab rückt ein bislang wenig bekanntes, aber hochaktuelles Phänomen in den Fokus: ARIA – Amyloid-related Imaging Abnormalities. +3 more findings

  24. 2025-10-23

    Privación del Sueño y Melatonina Factores que Influyen en la Enfermedad de Alzheimer: Revisión Sistemática

    ✓ Peer-reviewed Genetics Ciencia Latina Revista Científica Multidisciplinar

    Key finding: De 1.559 registros, se incluyeron 24 estudios. +4 more findings

  25. 2025-10-22

    Racial/ethnic differences in neuropsychological test performance in frontotemporal degeneration

    ✓ Peer-reviewed Disparities Alzheimer's & dementia (Amsterdam, Netherlands)

    Key finding: Minoritized individuals had lower scores and/or greater likelihood of impairment on measures of lexical retrieval, processing speed, cognitive flexibility, and working memory but not global cognition, verbal recall, attention, and category fluency. +4 more findings

Browse the library by subject, with the full score breakdown →